Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atricure (ATRC)
NASDAQ:ATRC
ATRC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$18.94 - $43.11
Previous CloseN/A
Volume180.64K
Average Volume (3M)615.32K
Market Cap
$1.91B
Enterprise Value$1.27B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.68
Next Earnings
Apr 30, 2025EPS Estimate
-0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.95
Shares Outstanding48,879,604
10 Day Avg. Volume607,750
30 Day Avg. Volume615,316
Standard Deviation0.13
R-Squared0.35
Alpha-0.00873
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.10
Price to Cash Flow (P/CF)81.70
P/FCF Ratio0.00
Enterprise Value/Market Cap0.66
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.65
Enterprise Value/Ebitda-97.90
Forecast
1Y Price Target
$53.50Price Target Upside36.62% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceATRC ended FY24 with Q4 revenue of $124.3M, ahead of consensus estimates, and delivered profitability ahead of expectations.
Product LaunchesThe launch of the Flex Mini device is expanding into new accounts, expected to be a tailwind for several years.
Strategic PartnershipsA newly announced partnership to incorporate PFA technology into its products is expected to provide additional growth opportunities.
Bears Say
Growth ConcernsMIS ablation and MIS appendage management growth are expected to decline in FY25.
Margin PressuresATRC's gross margin and operating margins were down year over year.
Valuation ConcernsATRC shares currently trade at ~3x EV/Revenue, which is believed not to reflect the potential upside from its multiple growth opportunities in 2025 and 2026.
---
Ownership Overview
3.17% Insiders
39.30% Mutual Funds
29.16% Other Institutional Investors
12.39% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ATRC FAQ
What was Atricure’s price range in the past 12 months?
Atricure lowest stock price was $18.94 and its highest was $43.11 in the past 12 months.
What is Atricure’s market cap?
Atricure’s market cap is $1.91B.
When is Atricure’s upcoming earnings report date?
Atricure’s upcoming earnings report date is Apr 30, 2025 which is in 67 days.
How were Atricure’s earnings last quarter?
Atricure released its earnings results on Feb 12, 2025. The company reported -$0.33 earnings per share for the quarter, missing the consensus estimate of -$0.202 by -$0.128.
Is Atricure overvalued?
According to Wall Street analysts Atricure’s price is currently Undervalued.
Does Atricure pay dividends?
Atricure does not currently pay dividends.
What is Atricure’s EPS estimate?
Atricure’s EPS estimate is -0.22.
How many shares outstanding does Atricure have?
Atricure has 48,879,604 shares outstanding.
What happened to Atricure’s price movement after its last earnings report?
Atricure reported an EPS of -$0.33 in its last earnings report, missing expectations of -$0.202. Following the earnings report the stock price went down -6.539%.
Which hedge fund is a major shareholder of Atricure?
Currently, no hedge funds are holding shares in ATRC
---
Atricure Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$53.50 (36.62% Upside)
$53.50 (36.62% Upside)
Blogger Sentiment
Bullish
ATRC Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.4%
Last 30 Days ▲ 10.8%
Last 30 Days ▲ 10.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.63%
12-Months-Change
Fundamentals
Return on Equity
-9.64%
Trailing 12-Months
Asset Growth
-0.75%
Trailing 12-Months
Company Description
Atricure
AtriCure, Inc. engages development, manufacture and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio Frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, Other International, and Total International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.
---
ATRC Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong year for AtriCure with significant revenue growth and improved profitability driven by new product launches and international expansion. However, challenges remain in the hybrid AF therapy segment in the U.S. and gross margin declines due to unfavorable mix. The outlook for 2025 is positive, with growth expected to continue, albeit with some pressures in specific segments.Read More>---
ATRC Stock 12 Month Forecast
Average Price Target
$53.50
▲(36.62% Upside)
Technical Analysis
Best Analysts Covering ATRC
1 Year
1 Year Success Rate
20/22 ratings generated profit
1 Year Average Return
+49.91%
reiterated a buy rating 9 days ago
Copying Suraj Kalia's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +49.91% per trade.
---